United Therapeutics (UTHR +1.3%) moves up after its board authorizes an additional $420M to its...

|About: United Therapeutics Corpora... (UTHR)|By:, SA News Editor

United Therapeutics (UTHR +1.3%) moves up after its board authorizes an additional $420M to its existing share repurchase program. The program will become effective on March 4 and remain open for up to one year. Separately, Standpoint Research ups the shares from Hold to Buy.